Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PERRIGO R AND D

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 54
  • 0 comments

FDA approve LANSOPRAZOLE

Comment Full text

GLENMARK PHARMS LTD

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 55
  • 0 comments

FDA approve LEVOFLOXACIN

Comment Full text

DR REDDYS LABS LTD

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 58
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text

BAYER HLTHCARE

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 44
  • 0 comments

FDA approve CIPROFLOXACIN

Comment Full text

SOMERSET THERAPS LLC

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 54
  • 0 comments

FDA approve NALBUPHINE HYDROCHLORIDE

Comment Full text

BAYER HLTHCARE

  • FDA Approval
  • Sept. 23, 2024, 08:53 UTC
  • 53
  • 0 comments

FDA approve CIPROFLOXACIN HYDROCHLORIDE

Comment Full text

UNIQUE PHARM

  • FDA Approval
  • Sept. 23, 2024, 08:35 UTC
  • 56
  • 0 comments

FDA approve ENALAPRIL MALEATE

Comment Full text

BIOVITRUM AB

  • FDA Approval
  • Sept. 20, 2024, 17:47 UTC
  • 63
  • 0 comments

FDA approve ANAKINRA

Comment Full text

ZEVRA DENMARK AS

  • FDA Approval
  • Sept. 20, 2024, 13:31 UTC
  • 59
  • 0 comments

FDA approve ARIMOCLOMOL

Comment Full text

HERITAGE PHARMA

  • FDA Approval
  • Sept. 20, 2024, 08:42 UTC
  • 47
  • 0 comments

FDA approve CITALOPRAM HYDROBROMIDE

Comment Full text
  • Previous
  • 350
  • 351
  • 352
  • 353
  • 354
  • Next

Search

News categories

  • Technical Exchange News(14648)
  • Event(6229)
  • SEC News(390614)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237949)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin